Adma Biologics (ADMA) Current Assets (2011 - 2026)
Adma Biologics' Current Assets was $575.86 million in Q3 2026, up 43.0% from $402.66 million a year earlier and up 9.0% from the prior quarter.
Adma Biologics (ADMA) Current Assets (2011 - 2026) Analysis & Trends
At the end of FY2025, Current Assets at Adma Biologics came in at $466.51 million, up 40.8% from FY2024.
- Current Assets shows a five-year compound annual growth rate of 24.9% (FY2020 to FY2025).
- In earlier years, Current Assets was $331.41 million in FY2024 (+28.9%), $257.01 million in FY2023 (-5.0%), $270.4 million in FY2022 (+29.5%) and $208.73 million in FY2021 (+35.8%).
- The Q3 2026 figure marks the highest quarterly Current Assets in data going back to Q4 2011.
- Compared with a year earlier, Current Assets has increased for 11 straight quarters, with growth averaging 34.5% over the last eight quarters.
- The best year-over-year quarter for Current Assets over five years was Q1 2026 (growth of 45.3%); the worst was Q4 2023 (a decline of 5.0%).
- Per Business Quant data, ADMA's Current Assets in the three quarters before Q3 2026 was $528.2 million (Q2 2026), $511.17 million (Q1 2026) and $466.51 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 65.26 Bn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 56.35 Bn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | 37.48 Bn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 38.94 Bn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | 31.45 Bn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 34.36 Bn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 16.55 Bn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 45.01 Bn |
| 10 | Adma Biologics | 2.87 Bn | 2.39 Bn | 99.92 Mn | 575.86 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 575.86 Mn |
| Jun 30, 2026 | 528.20 Mn |
| Mar 31, 2026 | 511.17 Mn |
| Dec 31, 2025 | 466.51 Mn |
| Sep 30, 2025 | 402.66 Mn |
| Jun 30, 2025 | 399.56 Mn |
| Mar 31, 2025 | 351.81 Mn |
| Dec 31, 2024 | 331.41 Mn |
| Sep 30, 2024 | 318.19 Mn |
| Jun 30, 2024 | 303.69 Mn |
| Mar 31, 2024 | 276.42 Mn |
| Dec 31, 2023 | 257.01 Mn |
| Sep 30, 2023 | 273.70 Mn |
| Jun 30, 2023 | 266.24 Mn |
| Mar 31, 2023 | 264.09 Mn |
| Dec 31, 2022 | 270.40 Mn |
| Sep 30, 2022 | 224.09 Mn |
| Jun 30, 2022 | 222.77 Mn |
| Mar 31, 2022 | 239.80 Mn |
| Dec 31, 2021 | 208.73 Mn |
Adma Biologics Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=ADMA&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "ADMA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=ADMA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();